Pages that link to "Q37274303"

The following pages link to Regenerative pharmacology in the treatment of genetic diseases: the paradigm of muscular dystrophy (Q37274303):

Displaying 21 items.

• Oxygen consumption and usage during physical exercise: the balance between oxidative stress and ROS-dependent adaptive signaling (Q28394742) (← links)
• Chromatin: the interface between extrinsic cues and the epigenetic regulation of muscle regeneration (Q33593168) (← links)
• TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. (Q34181742) (← links)
• Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway (Q34273936) (← links)
• Combined effect of AMPK/PPAR agonists and exercise training in mdx mice functional performance (Q34429838) (← links)
• Sculpting chromatin beyond the double helix: epigenetic control of skeletal myogenesis. (Q35212612) (← links)
• Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice (Q36771323) (← links)
• Preclinical studies in the mdx mouse model of duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat (Q36885666) (← links)
• The pharmacology of regenerative medicine (Q36974665) (← links)
• Comparative Genomics of X-linked Muscular Dystrophies: The Golden Retriever Model (Q37148808) (← links)
• "Mix of Mics"- Phenotypic and Biological Heterogeneity of "Multipotent" Muscle Interstitial Cells (MICs). (Q37637940) (← links)
• HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. (Q37729762) (← links)
• Current advances in cell therapy strategies for muscular dystrophies (Q37827157) (← links)
• Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases. (Q37838730) (← links)
• Invited review: Stem cells and muscle diseases: advances in cell therapy strategies (Q38269131) (← links)
• Histone deacetylase inhibitors: a potential epigenetic treatment for Duchenne muscular dystrophy. (Q38272315) (← links)
• Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs (Q42278257) (← links)
• Janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors (Q90633734) (← links)
• A Synthetic Gene Circuit for Self-Regulating Delivery of Biologic Drugs in Engineered Tissues (Q92994177) (← links)
• Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases (Q93138367) (← links)
• BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy (Q103803281) (← links)